Article

The clinicopathological features and possible physiological mechanisms of only EGFR-T790M primary mutation in lung adenocarcinoma patients

2024-01-30

Abstract excerpt

<title>Abstract</title> <p>The EGFR-T790M mutation often increases the difficulty of treatment in non-small cell lung cancer patients. The only EGFR-T790M primary mutation of the lung adenocarcinoma(LUAD) is rare, there are relatively few reports on the clinicopathological characteristics and physiological mechanisms of this disease. We collected the clinical data of LUAD patients with only EGFR-T790M primary mut...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9696e57e-f8c8-5b67-a300-9db85f730c93
DOI: 10.21203/rs.3.rs-3876301/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The clinicopathological features and possible physiological mechanisms of only EGFR-T790M primary mutation in lung adenocarcinoma patientsDOI 10.21203/rs.3.rs-3876301/v1Read

The clinicopathological features and possible physiological mechanisms of only the EGFR-T790M primary mutation in patients with lung adenocarcinoma.Semantic proximity Read

[Chinese Expert Consensus on Second-line Treatment for Non-small Cell Lung Cancer with Negative Driver Gene Mutations].Semantic proximity Read

[Driver genes and its clinical significance in non-small cell lung cancer].Semantic proximity Read

[Current Situation of Clinical Feature and Gene Phenotype of Young Adult Lung Cancer].Semantic proximity Read

The relationship between EGFR mutation status and clinic-pathologic features in pulmonary adenocarcinoma.Semantic proximity Read

Prevalence of driver mutations in non-small-cell lung cancers in the People&rsquo;s Republic of ChinaSemantic proximity Read

Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristicsSemantic proximity Read

Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinomaSemantic proximity Read

To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations.Semantic proximity Read

Throwing new light on lung cancer pathogenesis: updates on three recent topics.Semantic proximity Read

Efficacy Differences of First-line EGFR-TKIs Alone vs. in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alteration(s)Semantic proximity Read

[The Diagnosis and Treatment Guideline of Chinese Patients with EGFR Mutation and ALK Fusion Gene-Positive Non-Small Cell Lung Cancer (2013 Version)].Semantic proximity Read